China’s biotechnology market has “significantly” driven up the demand for primate experimental models as the market recovers, tightening the supply of laboratory monkeys, according to a leading biotech firm. The continued recovery of fundraising and out-licensing deals in innovative drugs in China this year has led to significant growth in the demand for primate experimental models, research firm Joinn Laboratories (China) said on Tuesday. Primate experiments typically use monkeys and other...